CAS 1207351-15-2

Codes: HQP-1351-004

Application context (from source-drug indications)

Chronic myeloid leukaemiaOlverembatinib髓系白血病加速期OlverembatinibGastrointestinal stromal tumourOlverembatinibMyeloid leukaemiaOlverembatinibLymphocytic leukaemiaOlverembatinibAcute lymphoblastic leukaemiaOlverembatinib

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Olverembatinib	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

OlverembatinibOriginator routesteps: 3total yield: /

methyl 3-iodo-4-methylbenzoate→4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline→3-iodo-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide→HQP-1351-004→HQP-1351-005→HQP-1351

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.